arrow_back Trending Legislation
Share share

Easier Access to Urgent-Use Compounded Medications

New rules aim to make it easier for hospitals and medical facilities to access urgently needed medications prepared individually by pharmacies when approved alternatives are unavailable. This means that in critical situations, patients can receive essential medications more quickly, improving treatment safety and effectiveness.
Key points
Compounded drugs can now be distributed in limited quantities to hospitals and clinics for urgent administration, even without an identified individual patient prescription at the time of compounding.
The prescribing practitioner must certify that reasonable attempts were made to obtain an FDA-approved drug or a drug from an outsourcing facility, but without success.
Packaging of compounded drugs must be marked to indicate urgent use and request patient identification records from the hospital or clinic.
Pharmacies are required to report adverse events associated with these compounded drugs to the FDA's MedWatch program.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Patient Access to Urgent-Use Pharmacy Compounding Act of 2021
Print number: HR 3662
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2021-06-01